TRCT
ENZ

Tower Research Capital (TRC)’s Enzo Biochem, Inc. ENZ Stock Holding History

Tower Research Capital (TRC)’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,026
Closed -$3.11K – 5674
2025
Q1 		$3.11K Sell
10,026
-2,887
-22% -$1.59K ﹤0.01% 4467
2024
Q4 		$9.22K Buy
12,913
+10,499
+435% +$10.9K ﹤0.01% 3924
2024
Q3 		$2.7K Sell
2,414
-1,849
-43% -$2.07K ﹤0.01% 4947
2024
Q2 		$4.65K Sell
4,263
-7,850
-65% -$8.84K ﹤0.01% 4755
2024
Q1 		$15.4K Buy
12,113
+3,828
+46% +$5.06K ﹤0.01% 3246
2023
Q4 		$11.5K Sell
8,285
-7,168
-46% -$9.51K ﹤0.01% 4126
2023
Q3 		$21.6K Buy
15,453
+5,544
+56% +$8.36K ﹤0.01% 3299
2023
Q2 		$18.2K Buy
9,909
+3,105
+46% +$7.19K ﹤0.01% 3472
2023
Q1 		$17K Sell
6,804
-19,252
-74% -$28.6K ﹤0.01% 3659
2022
Q4 		$37K Buy
26,056
+224
+0.9% +$437 ﹤0.01% 2573
2022
Q3 		$57K Sell
25,832
-6,960
-21% -$16.8K ﹤0.01% 3052
2022
Q2 		$68K Sell
32,792
-4,302
-12% -$10.6K ﹤0.01% 2613
2022
Q1 		$108K Buy
37,094
+9,768
+36% +$31.4K ﹤0.01% 2148
2021
Q4 		$88K Buy
+27,326
New +$93.2K ﹤0.01% 2322
2021
Q2 		– Sell
-14,887
Closed -$51K – 5922
2021
Q1 		$51K Sell
14,887
-11,625
-44% -$36.2K ﹤0.01% 3116
2020
Q4 		$67K Sell
26,512
-37,468
-59% -$81.6K ﹤0.01% 2790
2020
Q3 		$135K Buy
63,980
+49,056
+329% +$117K ﹤0.01% 2906
2020
Q2 		$33K Buy
+14,924
New +$38.4K ﹤0.01% 3389
2020
Q1 		– Sell
-10,301
Closed -$27K – 4064
2019
Q4 		$27K Buy
10,301
+10,140
+6,298% +$30.3K ﹤0.01% 1743
2019
Q3 		$1K Sell
161
-14,659
-99% -$51.9K ﹤0.01% 3945
2019
Q2 		$50K Buy
14,820
+12,570
+559% +$44.3K ﹤0.01% 1577
2019
Q1 		$6K Buy
+2,250
New +$7.36K ﹤0.01% 2985
2018
Q4 		– Sell
-28
Closed – – 4464
2018
Q3 		$0 Buy
+28
New +$127 ﹤0.01% 4326
2018
Q2 		– Sell
-1,082
Closed -$6K – 4137
2018
Q1 		$6K Sell
1,082
-7,970
-88% -$56.1K ﹤0.01% 2670
2017
Q4 		$74K Buy
9,052
+5,809
+179% +$55.5K 0.01% 1066
2017
Q3 		$34K Buy
+3,243
New +$36K ﹤0.01% 2326
2017
Q1 		– Sell
-718
Closed -$5K – 4054
2016
Q4 		$5K Sell
718
-708
-50% -$4.52K ﹤0.01% 3080
2016
Q3 		$7K Buy
+1,426
New +$8.52K ﹤0.01% 2358
2016
Q2 		– Sell
-883
Closed -$4K – 5075
2016
Q1 		$4K Buy
+883
New +$3.93K ﹤0.01% 2950
2015
Q4 		– Sell
-4,288
Closed -$14K – 5146
2015
Q3 		$14K Sell
4,288
-2,536
-37% -$7.69K ﹤0.01% 2047
2015
Q2 		$21K Buy
6,824
+3,981
+140% +$11.2K ﹤0.01% 2060
2015
Q1 		$8K Buy
+2,843
New +$9.31K ﹤0.01% 2981
2014
Q4 		– Sell
-9,680
Closed -$50K – 4792
2014
Q3 		$50K Sell
9,680
-4,736
-33% -$25.3K 0.01% 1534
2014
Q2 		$75K Buy
+14,416
New +$62.3K 0.01% 1052
2014
Q1 		– Sell
-443
Closed -$1K – 5026
2013
Q4 		$1K Buy
443
+354
+398% +$878 ﹤0.01% 4270
2013
Q3 		$0 Buy
+89
New +$211 ﹤0.01% 4901

Other funds holding ENZ

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Tower Research Capital (TRC)'s ENZ Position: Q2 2025 in Review

Tower Research Capital (TRC) sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 10,026 shares — an estimated $3.11K sold.

Tower Research Capital (TRC) first reported a position in ENZ in Q3 2013 and held it in 36 quarters. The position peaked at $135K in Q3 2020. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

  • Tower Research Capital (TRC) reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 10,026 Enzo Biochem, Inc. shares in Q2 2025, an estimated $3.11K.
  • Tower Research Capital (TRC) first reported a position in Enzo Biochem, Inc. in Q3 2013 and held it in 36 quarters.
  • Tower Research Capital (TRC)'s Enzo Biochem, Inc. position peaked at $135K in Q3 2020.
  • 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.